From Medscape Oncology

Medscape Medical News from the:

35th Annual San Antonio Breast Cancer Symposium (SABCS)

December 04 - 08, 2012; San Antonio, Texas

This coverage is not sanctioned by, nor a part of, the supporters of the San Antonio
Breast Cancer Symposium

Meeting Highlights at a Glance

Top News From SABCS 2012: Slideshow
Highlights of this year's conference include dramatic improvement in progression-free survival when an experimental cell-cycle inhibitor is added to letrozole; 10 years of adjuvant tamoxifen is worth it (the ATLAS study); and chemotherapy for an isolated breast cancer recurrence has value.


Making Headway in Brain Metastases
Drs. Lidia Schapira and Nancy Lin discuss the most recent data on treatment and outcomes of central nervous system metastases in breast cancer.

Issues in Treating Older Women With Breast Cancer
Striking the balance between over- and undertreatment requires a special approach in older women with breast cancer.

When Is Less Surgery Beneficial in Breast Cancer?
Dr. Judy Boughey describes a technique that might spare many women the ordeal of axillary lymph node dissection.

Is Breast Cancer More Deadly in the Young?
Sibylle Loibl explains the special considerations for treating breast cancer in young women, including the treatment of breast cancer during pregnancy.

Conference News

Medscape Oncology©  WebMD, LLC

Medscape Oncology Insights

Everolimus: Avalanche of mTOR Data in ER+ Breast Cancer
Lidia Schapira, MD;
Fabrice André, MD, PhD

Is Neoadjuvant BEV Right for Triple-Negative Disease?
Lidia Schapira, MD;
Gunter von Minckwitz, MD, PhD

A New Way to Tackle Triple-Negative Breast Cancer?
Kathy D. Miller, MD;
Carlos L. Arteaga, MD

ATLAS: No Shrugging These Results
Kathy D. Miller, MD;
Harold J. Burstein, MD

HER2-Positive Disease: No Need for Chemo?
Kathy D. Miller, MD;
José M. Baselga, MD, PhD

Local-Regional Control Improves Breast Cancer Survival
Kathy D. Miller, MD;
Thomas A. Buchholz, MD

Pre-Meeting Expert Commentary

SABCS Preview: Watch for Sentinel Node Studies
Kathy D. Miller, MD